Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)
Clinical trial NCT06193239 · COMPLETED
Trial details
- NCT number
- NCT06193239
- Sponsor
- Owlstone Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-05
- Primary completion
- 2025-05-29
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.